125 related articles for article (PubMed ID: 51285)
1. Idiopathic parkinsonism treated with bromocriptine.
Teychenne PF; Leigh PN; Reid JL; Calne DB; Greenacre JK; Petrie A; Bamji AN
Lancet; 1975 Sep; 2(7933):473-6. PubMed ID: 51285
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine in Parkinsonism.
Calne DB; Teychenne PF; Claveria LE; Eastman R; Greenacre JK; Petrie A
Br Med J; 1974 Nov; 4(5942):442-4. PubMed ID: 4425916
[TBL] [Abstract][Full Text] [Related]
4. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
5. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine in the treatment of advanced Parkinsonism.
Kristensen O; Hansen E
Acta Neurol Scand; 1977 Sep; 56(3):274-6. PubMed ID: 333856
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine: low-dose therapy in Parkinson disease.
Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
[TBL] [Abstract][Full Text] [Related]
9. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Libman I; Gawel MJ; Riopelle RJ; Bouchard S
Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of bromocriptine in Parkinson disease.
Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Bear G; Goldstein M
Neurology; 1980 May; 30(5):518-23. PubMed ID: 6768003
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pergolide and bromocriptine therapy in parkinsonism.
LeWitt PA; Ward CD; Larsen TA; Raphaelson MI; Newman RP; Foster N; Dambrosia JM; Calne DB
Neurology; 1983 Aug; 33(8):1009-14. PubMed ID: 6348585
[TBL] [Abstract][Full Text] [Related]
12. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
13. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
Jansen EN
Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
[TBL] [Abstract][Full Text] [Related]
14. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Hely MA; Morris JG; Reid WG; O'Sullivan DJ; Williamson PM; Rail D; Broe GA; Margrie S
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):903-10. PubMed ID: 8057111
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Parkinson's disease with lergotrile mesylate.
Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M
JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094
[TBL] [Abstract][Full Text] [Related]
16. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
17. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
Hely MA; Morris JG; Rail D; Reid WG; O'Sullivan DJ; Williamson PM; Genge S; Broe GA
J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):324-8. PubMed ID: 2647907
[TBL] [Abstract][Full Text] [Related]
18. Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Aug; 26(8):741-3. PubMed ID: 181692
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
Agid Y; Pollak P; Bonnet AM; Signoret JL; Lhermitte F
Lancet; 1979 Mar; 1(8116):570-2. PubMed ID: 85162
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Marsden CD
Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
